Literature DB >> 19625914

Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.

Marie Blanchette1, Martin Pellerin, Luc Tremblay, Martin Lepage, David Fortin.   

Abstract

OBJECTIVE: Treatment of malignant gliomas is hampered by several factors, one of which is the blood-brain barrier (BBB). Thus, innovative strategies to cross the BBB have been developed, such as the BBB disruption procedure. Although it has been studied extensively, details regarding the physiology of the procedure remain obscure. This study was undertaken to clarify these issues.
METHODS: Forty Wistar rats were imaged with a 7T animal magnetic resonance imaging scanner in dynamic acquisitions during BBB disruption. Gadolinium diethylenetriamine penta-acetic acid (Gd-DTPA) was injected to visualize and characterize the permeability of the BBB at different time points after disruption. The concentration of Gd-DTPA in the brain parenchyma was determined as a function of time after injection.
RESULTS: A typical pattern of signal change as a function of time was observed in the treated hemisphere of all animals. Initially, a slight signal decrease was observed in T1-weighted images followed by a strong increase corresponding to the injection of Gd-DTPA. Two different mechanisms seemed responsible for the distribution of Gd-DTPA within the parenchyma: 1) a direct diffuse increase in capillary permeability, and 2) a diffusion process in the interstitial compartment. Initial results showed that the barrier opens immediately after the procedure and for at least 30 minutes.
CONCLUSION: The methodology described in this article allows monitoring of the dynamics of the BBB disruption process and characterization of its physiology in vivo, and represents a marked advantage over postmortem static studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625914     DOI: 10.1227/01.NEU.0000349762.17256.9E

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

Review 1.  Therapeutic strategies to improve drug delivery across the blood-brain barrier.

Authors:  Tej D Azad; James Pan; Ian D Connolly; Austin Remington; Christy M Wilson; Gerald A Grant
Journal:  Neurosurg Focus       Date:  2015-03       Impact factor: 4.047

2.  Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.

Authors:  Gabriel Charest; Léon Sanche; David Fortin; David Mathieu; Benoit Paquette
Journal:  J Neurooncol       Date:  2013-09-13       Impact factor: 4.130

3.  Impact of drug size on brain tumor and brain parenchyma delivery after a blood-brain barrier disruption.

Authors:  Marie Blanchette; Luc Tremblay; Martin Lepage; David Fortin
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-12       Impact factor: 6.200

4.  Serum osmolality, cerebrospinal fluid specific gravity and overt hepatic encephalopathy severity in patients with liver failure.

Authors:  Eric M Liotta; Constantine J Karvellas; Minjee Kim; Ayush Batra; Andrew Naidech; Shyam Prabhakaran; Farzaneh A Sorond; W Taylor Kimberly; Matthew B Maas
Journal:  Liver Int       Date:  2020-02-12       Impact factor: 5.828

Review 5.  Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Authors:  Eric M Liotta; W Taylor Kimberly
Journal:  Neurosci Lett       Date:  2020-02-05       Impact factor: 3.046

6.  Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption.

Authors:  Conor P Foley; David G Rubin; Alejandro Santillan; Dolan Sondhi; Jonathan P Dyke; Ronald G Crystal; Y Pierre Gobin; Douglas J Ballon
Journal:  J Control Release       Date:  2014-09-28       Impact factor: 9.776

7.  Permeability dependence study of the focused ultrasound-induced blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRI.

Authors:  Fotios Vlachos; Yao-Sheng Tung; Elisa Konofagou
Journal:  Magn Reson Med       Date:  2011-04-04       Impact factor: 4.668

Review 8.  Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.

Authors:  Ann-Marie Chacko; Chunsheng Li; Daniel A Pryma; Steven Brem; George Coukos; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2013-06-11       Impact factor: 6.648

9.  Drug Delivery Strategies to Overcome the Blood-Brain Barrier (BBB).

Authors:  Hans Christian Cederberg Helms; Mie Kristensen; Lasse Saaby; Gert Fricker; Birger Brodin
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Vascular endothelial growth factors enhance the permeability of the mouse blood-brain barrier.

Authors:  Shize Jiang; Rui Xia; Yong Jiang; Lei Wang; Fabao Gao
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.